World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat

Hidekazu Suzuki, Hideki Mori

Research output: Contribution to journalReview articlepeer-review

55 Citations (Scopus)

Abstract

Helicobacter pylori-associated gastritis leads to the development of gastric cancer. Kyoto global consensus report on H. pylori gastritis recommended H. pylori eradication therapy to prevent gastric cancer. To manage H. pylori infection, it is important to choose the appropriate regimen considering regional differences in resistance to clarithromycin and metronidazole. Quinolones and rifabutin-containing regimens are useful as third- and fourth-line rescue therapies.

Original languageEnglish
Pages (from-to)354-361
Number of pages8
JournalJournal of gastroenterology
Volume53
Issue number3
DOIs
Publication statusPublished - 2018 Mar 1

Keywords

  • Clarithromycin
  • Fluoroquinolone
  • Gastric cancer
  • H. pylori
  • Metronidazole

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat'. Together they form a unique fingerprint.

Cite this